WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

What this Trial Is About

Researchers are evaluating the implementation and effectiveness of continuous wireless monitoring of vital signs with real-time alerts in patients who are either at home or hospitalized. This study focuses on high-risk patients with acute conditions or those undergoing major elective surgery, aiming to improve detection of physiological changes that may indicate clinical deterioration. The study builds on the WARD project, which integrates continuous measurements of multiple physiological signals with artificial intelligence to support clinical decision-making. Participants will have their vital signs continuously monitored using a specially developed app that collects data through a wireless device. The WARD-Clinical Support System (WARD-CSS) uses machine learning algorithms to interpret the data, predict potential health issues, and alert clinical staff via a mobile device with an easy-to-use interface. The study includes patients at home, during hospitalization, and after surgery, assessing how well the system works in these settings. During the study, participants' vital signs data quality and clinical user satisfaction will be tracked over 30 days. The researchers will evaluate how often patients are monitored with sufficient data quality and how satisfied clinical users are with the system. Participants may undergo assessments and monitoring through the app without interfering with their usual care. Safety and ease of use will be important aspects of the study's observations.

Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization